Skip to content

UltraClip® II Breast Tissue Marker 861217Recalls & reported problems

Bard Peripheral Vascular, Inc. · ULTRACLIP® II breast tissue marker 17g x 12cm needle, titanium ribbon clip · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741032271), received between Aug 29, 2019 and Aug 29, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Patient-Device Incompatibility1

Patient problems

  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 29, 2019Patient-Device Incompatibility; Adverse Event Without Identified Device or Use Problem; Patient-Device Incompatibility; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ONE WEEK AFTER PLACEMENT OF A BREAST TISSUE MARKER, THE PATIENT IS EXPERIENCING SEVERE PAIN AND REDNESS. THE MARKER IS NOT SCHEDULED TO BE REMOVED AT THIS MOMENT.

    Patient problems: Pain

    MAUDE report 8947306 ↗

Other STAPLE, IMPLANTABLE devices

All STAPLE, IMPLANTABLE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page